MINNEAPOLIS, Feb. 4 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will release financial results for the third quarter of fiscal 2008 ended December 31, 2007, before the market opens on Monday, February 11, 2008. The Company will host a conference call to discuss these results on Monday, February 11, 2008 at 10:00 a.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 800-240-5318 (domestic) or 303-262-2140 (international). An audio replay will be available for 7 days following the call at 800-405-2236 (domestic) or 303-590-3000 (international), with the passcode 11108161#.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with
wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a
medical device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our primary
focus is the commercialization of our Urgent PC(R) system, which we believe
is the only FDA-approved non-surgical neurostimulation therapy for the
treatment of overactive bladder symptoms (OAB). We also offer
Macroplastique(R) Implants, a bulking agent for the treatment of urinary
incontinence. Please visit Uroplasty, Inc. at http://www.uroplasty.com.
For Further Information:
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, and Treasurer,
Matthew Selinger (Investors)
Chris Gale (Media)
|SOURCE Uroplasty, Inc.|
Copyright©2008 PR Newswire.
All rights reserved